Literature DB >> 9869649

A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E.

Y Xu1, L Berglund, R Ramakrishnan, R Mayeux, C Ngai, S Holleran, B Tycko, T Leff, N S Shachter.   

Abstract

Apolipoprotein (apo) C-I is a constituent of triglyceride-rich lipoproteins (TGRL) that interferes with their hepatic clearance. Functional polymorphism in the apoC-I gene has not been established. We determined that an Hpa I site variably present at -317 relative to the apoC-I gene is produced by a 4-bp CGTT insertion. The apoC-I Hpa I alleles showed an ethnically distinct pattern of linkage disequilibrium with the alleles of the adjacent apoE gene. The frequency of apoC-I Hpa I-positive (H2) with apoE varepsilon2 was 0. 98, without significant ethnic difference. In contrast, the frequency of H2 with apoE epsilon4 was 0.85 in European-Americans but only 0.55 in African-Americans (P < 0.001). The frequency of H2 with apoE epsilon3 was 0.02 in European-Americans and 0.08 in African-Americans (P < 0.001). African-American apoE epsilon3/epsilon3 carriers of apoC-I H2 had 19% lower fasting triglyceride levels than H1 homozygotes (P = 0.03) along with 18% higher HDL-cholesterol levels (P = 0.02). ApoB levels were 21% lower (P = 0.002). H2-allelic reporter-gene constructions showed 50% higher expression in transient transfection studies. We localized the source of this difference in expression to the CGTT insertion itself. Deletion studies of the H1 allele showed a negative transcriptional effect of the polymorphic region. An H1 oligodeoxynucleotide showed specific binding of a hepatoma-cell nuclear protein not evident with an H2 oligodeoxynucleotide. The H2 sequence may decrease the binding of a negatively acting transcription factor, leading to overexpression of apoC-I. This may produce a functional effect on lipoprotein levels but confirmation is needed in other populations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9869649

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  19 in total

1.  A comprehensive genetic association study of Alzheimer disease in African Americans.

Authors:  Mark W Logue; Matthew Schu; Badri N Vardarajan; Jacki Buros; Robert C Green; Rodney C P Go; Patrick Griffith; Thomas O Obisesan; Rhonna Shatz; Amy Borenstein; L Adrienne Cupples; Kathryn L Lunetta; M Daniele Fallin; Clinton T Baldwin; Lindsay A Farrer
Journal:  Arch Neurol       Date:  2011-12

2.  Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease.

Authors:  Xavier Pillois; Thomas Gautier; Benjamin Bouillet; Jean-Paul Pais de Barros; Aline Jeannin; Bruno Vergès; Jacques Bonnet; Laurent Lagrost
Journal:  J Lipid Res       Date:  2012-04-02       Impact factor: 5.922

3.  Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism.

Authors:  S M Fullerton; A G Clark; K M Weiss; D A Nickerson; S L Taylor; J H Stengârd; V Salomaa; E Vartiainen; M Perola; E Boerwinkle; C F Sing
Journal:  Am J Hum Genet       Date:  2000-09-13       Impact factor: 11.025

Review 4.  Genetic determinants of plasma triglycerides: impact of rare and common mutations.

Authors:  P J Talmud
Journal:  Curr Atheroscler Rep       Date:  2001-05       Impact factor: 5.113

5.  Apolipoproteins E and C1 and brain morphology in memory impaired elders.

Authors:  J M Serra-Grabulosa; P Salgado-Pineda; C Junqué; C Solé-Padullés; P Moral; A López-Alomar; T López; A López-Guillén; N Bargalló; J M Mercader; I C Clemente; D Bartrés-Faz
Journal:  Neurogenetics       Date:  2002-12-21       Impact factor: 2.660

6.  WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.

Authors:  Yannick Cyr; Hanny Wassef; Simon Bissonnette; Valerie Lamantia; Jean Davignon; May Faraj
Journal:  J Lipid Res       Date:  2016-04-03       Impact factor: 5.922

7.  ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans.

Authors:  Erdembileg Anuurad; Masayuki Yamasaki; Neil Shachter; Thomas A Pearson; Lars Berglund
Journal:  J Lipid Res       Date:  2009-02-27       Impact factor: 5.922

8.  What are lipoproteins doing in the brain?

Authors:  Hong Wang; Robert H Eckel
Journal:  Trends Endocrinol Metab       Date:  2013-11-02       Impact factor: 12.015

9.  Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer.

Authors:  Jie Yi; Liwen Ren; Jie Wu; Wan Li; Xiangjin Zheng; Guanhua Du; Jinhua Wang
Journal:  Ann Transl Med       Date:  2019-08

10.  Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease.

Authors:  Raoudha Bahri; Esther Esteban; Pedro Moral; Mohsen Hassine; Khaldoun Ben Hamda; Hassen Chaabani
Journal:  Lipids Health Dis       Date:  2008-11-17       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.